Blood biomarkers for inflammatory breast cancer
Researchers have found blood-based biomarkers that can distinguish inflammatory breast cancer (IBC) from other breast cancer types. Using a robust RNA method, the discovery could allow earlier detection, easier monitoring and help guide new treatments.